In 2023, the Chinese Center for Drug Evaluation of the National Medical Products Administration (NMPA) approved 186 New Drug Applications (NDA) for chemical drugs. 22 percent of all chemical drugs approved were antineoplastic drugs. Anti-infectives and drugs treating nervous system diseases were also approved in considerable numbers. A New Drug Application (NDA) is the mechanism through which pharmaceutical manufacturers propose that the regulatory body approve a new drug or biopharmaceutical for general use and sale.
Distribution of therapeutic areas for approved chemical drug New Drug Applications (NDA) in China in 2023
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
National Medical Products Administration. (February 4, 2024). Distribution of therapeutic areas for approved chemical drug New Drug Applications (NDA) in China in 2023 [Graph]. In Statista. Retrieved November 21, 2024, from https://www.statista.com/statistics/1320104/china-therapeutic-for-approved-chemical-drug-nda/
National Medical Products Administration. "Distribution of therapeutic areas for approved chemical drug New Drug Applications (NDA) in China in 2023." Chart. February 4, 2024. Statista. Accessed November 21, 2024. https://www.statista.com/statistics/1320104/china-therapeutic-for-approved-chemical-drug-nda/
National Medical Products Administration. (2024). Distribution of therapeutic areas for approved chemical drug New Drug Applications (NDA) in China in 2023. Statista. Statista Inc.. Accessed: November 21, 2024. https://www.statista.com/statistics/1320104/china-therapeutic-for-approved-chemical-drug-nda/
National Medical Products Administration. "Distribution of Therapeutic Areas for Approved Chemical Drug New Drug Applications (Nda) in China in 2023." Statista, Statista Inc., 4 Feb 2024, https://www.statista.com/statistics/1320104/china-therapeutic-for-approved-chemical-drug-nda/
National Medical Products Administration, Distribution of therapeutic areas for approved chemical drug New Drug Applications (NDA) in China in 2023 Statista, https://www.statista.com/statistics/1320104/china-therapeutic-for-approved-chemical-drug-nda/ (last visited November 21, 2024)
Distribution of therapeutic areas for approved chemical drug New Drug Applications (NDA) in China in 2023 [Graph], National Medical Products Administration, February 4, 2024. [Online]. Available: https://www.statista.com/statistics/1320104/china-therapeutic-for-approved-chemical-drug-nda/
